Showing results (121-130 of 1,967,859) with videos related to
Sort By:
Pageof 196,786
Breast Cancer (Dove Medical Press)|April 28, 2023
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A ReviewJin Wang, Dongying Liao, Xuemin Zhang, et al.Plos One|February 12, 2025
The impact of rural revitalization talent cultivation on farm household part-time farming: Evidence from the "One Village, One University Student" programJiawei Wang, Xia Kuang, Zhipeng Wang, et al.Journal of Food Science|August 2, 2021
Study on the water state, migration, and microstructure modification during the process of salt-reduced stewed duckRui Li, Wei Kuang, Yili Hu, et al.Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|July 20, 2013
[Effects of electrical stimulation on the differentiation of mesenchymal stem cells into cardiomyocyte-like cells]Zhongqin Yan, Gang Yang, Liao Cui, et al.Scientific Reports|February 8, 2025
Tunnel face stability in strata rich in water with soft upper and hard lower layersTao Zhan, Ziwei Hu, Yan Kuang, et al.Cellular & Molecular Biology Letters|May 1, 2020
LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5Zheng Zhang, Xiaoxuan Hu, Jia Kuang, et al.Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|March 4, 2009
[Combined indicators for diagnosing immune thrombocytopenic purpura]Jing Zhou, Neng-gang Jiang, Ling-han Kuang, et al.Frontiers in Nutrition|January 5, 2026
From digitalization to nutrition: the role of digital village construction in shaping dietary intake of rural residents in ChinaJiawei Wang, Xia Kuang, Zhihua Wu, et al.Cell Biology International|February 10, 2022
Rifaximin protects SH-SY5Y neuronal cells from iron overload-induced cytotoxicity via inhibiting STAT3/NF-κB signalingZheng Zhang, Qi Yuan, Xiaoxuan Hu, et al.Journal of Gastrointestinal Oncology|September 15, 2025
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironmentMingfang Xu, Yingda Liu, Xunjie Kuang, et al.Pageof 196,786